Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boston Scientific Buys Cameron Health For First Subcutaneous ICD

This article was originally published in The Gray Sheet

Executive Summary

Deal includes $150 million up front, but is worth up to $1.35 billion with potential milestone payments.

You may also be interested in...

S-ICD Registry Supports Broad Use Of Technology, Investigator Says

Data from the 985-patient EFFORTLESS registry was presented at this year's Heart Rhythm Society annual meeting, lending support for Boston Scientific's subcutaneous ICD system, according to study investigators. The company envisions a future, "modular" approach to cardiac rhythm management.

Boston Scientific Gets Early Nod For Next Gen S-ICD

Boston's Emblem S-ICD upgrade was approved by FDA and in Europe earlier than anticipated.

Boston Scientific Continues Worldwide Restructuring, Plans Job Cuts

The cuts expand on a 2011 restructuring plan, with hopes of reducing operating expenses by up to $375 million at the end of 2013.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts